These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16164649)

  • 1. Gender hormones and the progression of experimental polycystic kidney disease.
    Stringer KD; Komers R; Osman SA; Oyama TT; Lindsley JN; Anderson S
    Kidney Int; 2005 Oct; 68(4):1729-39. PubMed ID: 16164649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelial-derived vasoactive mediators in polycystic kidney disease.
    Al-Nimri MA; Komers R; Oyama TT; Subramanya AR; Lindsley JN; Anderson S
    Kidney Int; 2003 May; 63(5):1776-84. PubMed ID: 12675853
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and renal injury in experimental polycystic kidney disease.
    Kennefick TM; Al-Nimri MA; Oyama TT; Thompson MM; Kelly FJ; Chapman JG; Anderson S
    Kidney Int; 1999 Dec; 56(6):2181-90. PubMed ID: 10594794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.
    Cowley BD; Rupp JC; Muessel MJ; Gattone VH
    Am J Kidney Dis; 1997 Feb; 29(2):265-72. PubMed ID: 9016899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of renal innervation to hypertension in rat autosomal dominant polycystic kidney disease.
    Gattone VH; Siqueira TM; Powell CR; Trambaugh CM; Lingeman JE; Shalhav AL
    Exp Biol Med (Maywood); 2008 Aug; 233(8):952-7. PubMed ID: 18480417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen and angiotensin II interactions determine cardio-renal damage in Dahl salt-sensitive rats with heart failure.
    Hoshi-Fukushima R; Nakamoto H; Imai H; Kanno Y; Ishida Y; Yamanouchi Y; Suzuki H
    Am J Nephrol; 2008; 28(3):413-23. PubMed ID: 18097133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoregulation of renal blood flow and pressure-dependent renin release in autosomal dominant polycystic kidney disease of rats.
    Braun C; Lüdicke C; Rebsch W; Gretz N; van der Woude FJ; Rohmeiss P
    Nephrol Dial Transplant; 1996; 11 Suppl 6():52-7. PubMed ID: 9044329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The expression and activity of renal nitric oxide synthase and circulating nitric oxide in polycystic kidney disease rats.
    Wang D; Braendstrup O; Larsen S; Horn T; Strandgaard S
    APMIS; 2004 Jun; 112(6):358-68. PubMed ID: 15511273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variable renal disease progression in autosomal dominant polycystic kidney disease: a role for nitric oxide?
    Devuyst O
    J Nephrol; 2003; 16(3):449-52. PubMed ID: 12832751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of nitric oxide on renal interstitial fibrosis in rats with unilateral ureteral obstruction.
    Sun D; Wang Y; Liu C; Zhou X; Li X; Xiao A
    Life Sci; 2012 Jun; 90(23-24):900-9. PubMed ID: 22572614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal concentration of alpha-tocopherol: dependence on gender and lack of effect on polycystic kidney disease in Han:SPRD rats.
    Torres VE; Bengal RJ; Nickander KK; Grande JP; Low PA
    Am J Kidney Dis; 1998 Apr; 31(4):687-93. PubMed ID: 9531187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary arginine supplementation attenuates renal damage after relief of unilateral ureteral obstruction in rats.
    Ito K; Chen J; Seshan SV; Khodadadian JJ; Gallagher R; El Chaar M; Vaughan ED; Poppas DP; Felsen D
    Kidney Int; 2005 Aug; 68(2):515-28. PubMed ID: 16014028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection.
    Kang DH; Yu ES; Yoon KI; Johnson R
    Am J Pathol; 2004 Feb; 164(2):679-88. PubMed ID: 14742271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
    Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
    Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of estrogens on cardiovascular structure in uninephrectomized SHRsp rats.
    Gross ML; Ritz E; Korsch M; Adamczak M; Weckbach M; Mall G; Berger I; Hansen A; Amann K
    Kidney Int; 2005 Mar; 67(3):849-57. PubMed ID: 15698424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemorrhagic shock-induced vascular hyporeactivity in the rat: relationship to gene expression of nitric oxide synthase, endothelin-1, and select cytokines in corresponding organs.
    Liu LM; Dubick MA
    J Surg Res; 2005 May; 125(2):128-36. PubMed ID: 15854664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ETA receptor blockade induces tubular cell proliferation and cyst growth in rats with polycystic kidney disease.
    Hocher B; Kalk P; Slowinski T; Godes M; Mach A; Herzfeld S; Wiesner D; Arck PC; Neumayer HH; Nafz B
    J Am Soc Nephrol; 2003 Feb; 14(2):367-76. PubMed ID: 12538737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.